Description
Sensitivity analysis results testing the robustness of the Bayesian network meta-analysis findings to different prior specifications and model assumptions for AGA treatment comparisons.
FIGURE 7
ChartSource Paper
Hair regrowth treatment efficacy and resistance in androgenetic alopecia: A systematic review and continuous Bayesian network meta-analysis.Cite This Figure
 > Source: Peter R Feldman et al. "Hair regrowth treatment efficacy and resistance in androgenetic alopecia: A syst." *Frontiers in medicine*, 2022. PMID: [36755885](https://pubmed.ncbi.nlm.nih.gov/36755885/)
<figure> <img src="https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9900126/bin/fmed-09-998623-g007.jpg" alt="Sensitivity analysis results testing the robustness of the Bayesian network meta-analysis findings to different prior specifications and model assumptions for AGA treatment comparisons." /> <figcaption>FIGURE 7. Sensitivity analysis results testing the robustness of the Bayesian network meta-analysis findings to different prior specifications and model assumptions for AGA treatment comparisons.<br> Source: Peter R Feldman et al. "Hair regrowth treatment efficacy and resistance in androgenetic alopecia: A syst." <em>Frontiers in medicine</em>, 2022. PMID: <a href="https://pubmed.ncbi.nlm.nih.gov/36755885/">36755885</a></figcaption> </figure>
Preuves associées
A
Minoxidil pour Alopécie Androgénétique
A
Note A · 299 études
Finasteride pour Alopécie Androgénétique
A
Note A · 206 études
Nutrafol pour Alopécie Androgénétique
A
Note A · 3 études
Thérapie laser de faible intensité pour Alopécie Androgénétique
A
Note A · 60 études
Viviscal pour Telogen Effluvium
A
Note A · 8 études
Viviscal pour Amincissement Capillaire Lié à l'Âge
A
Note A · 8 études
Nutrafol pour Perte Capillaire Féminine
A
Note A · 8 études
Nutrafol pour Perte Capillaire Liée au Stress
A
Note A · 8 études
Dutasteride pour Alopécie Androgénétique
Note A · 99 études